HERO:
Help Expand Research Opportunities
The Challenge
Montana has the 6th oldest population ratio in the nation, with 18.5% of our total population over the age of 65. Given that the risk of development of neurodegenerative diseases increases with age, promoting the expansion of science and medicine via clinical research that targets advancements in diagnosis, treatment, and prevention of neurodegenerative diseases is a priority concern in our state.
The Need
The need for clinical research expansion in our state is vital. Montana has consistently ranked in the bottom 10% when it comes to participation and representation in clinical research in the United States. Of the clinical research that has been done in Montana, the vast majority of studies have focused on cancer research, with only 7.6% of total studies over time focusing on neurological disorders, and a meager 0.3% aimed at Alzheimer’s disease which, according to 2020 data from National Center for Health Statistics, is the 7th leading cause of death both nationally and locally in Montana.
The Solution
Scientists at the Institute are spearheading this patient registry which allows the Institute to enroll Montanans in potential clinical trials and research studies. They will use the registry to enroll individuals with mild cognitive impairment, Alzheimer’s, Parkinson’s, ALS and age-related macular degeneration, as well as individuals with no chronic disease as studies may seek healthy control participants.
